Bonnie W. Ramsey is an American pediatric pulmonologist and researcher. She is a professor emerita of pediatrics at the University of Washington School of Medicine and has held the Bonnie W. Ramsey, M.D. Endowed Chair in Cystic Fibrosis. [1] [2] She served as director of the Center for Clinical and Translational Research at Seattle Children’s Research Institute from 2007 to 2021. [3] Her research has focused on developing new therapies for cystic fibrosis, including clinical trials supporting the first CFTR modulator therapy, ivacaftor (Kalydeco). [4] [5]
Ramsey received a B.A. from Stanford University in 1972 and an M.D. from Harvard Medical School in 1976. [4] [6] She completed pediatric residency training at Boston Children’s Hospital and training at Seattle Children’s Hospital. [4]
Ramsey’s academic career was based at the University of Washington School of Medicine, where she served as a professor (and later professor emerita) of pediatrics and vice chair for research in the Department of Pediatrics. [2] [7] In 2005, the Bonnie W. Ramsey, M.D. Professorship in Cystic Fibrosis was upgraded to an endowed chair, with Ramsey named as its first holder. [1]
She helped establish the Cystic Fibrosis Foundation’s Therapeutics Development Network (TDN) and led the network from 1998 to 2015, supporting multicenter clinical trials for cystic fibrosis therapies. [8] [9] [4]
Ramsey participated in the design and oversight of clinical trials supporting the development and U.S. Food and Drug Administration approval of ivacaftor, the first CFTR modulator therapy, in 2012. [4] [5]
Ramsey retired from full-time faculty work in 2022 and has continued in advisory roles, including as a senior advisor to the Cystic Fibrosis Foundation Therapeutics Development Network. [10] [3]
Ramsey was elected to the National Academy of Medicine in 2015. [11]
In 2018, she was a recipient of the Warren Alpert Foundation Prize. [4] [12]
In 2025, Ramsey received the John Howland Award from the American Pediatric Society. [13]